Changes in body shape and metabolic abnormalities.
D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D008060:Lipodystrophy / Q000139:chemically induced*; D008297:Male
D017320:HIV Protease Inhibitors